260 related articles for article (PubMed ID: 32987711)
21. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.
Paulsen EE; Kilvaer TK; Rakaee M; Richardsen E; Hald SM; Andersen S; Busund LT; Bremnes RM; Donnem T
Cancer Immunol Immunother; 2017 Nov; 66(11):1449-1461. PubMed ID: 28707078
[TBL] [Abstract][Full Text] [Related]
22. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
[TBL] [Abstract][Full Text] [Related]
23. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
[TBL] [Abstract][Full Text] [Related]
24. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.
Kang MW; Lee ES; Yoon SY; Jo J; Lee J; Kim HK; Choi YS; Kim K; Shim YM; Kim J; Kim H
J Int Med Res; 2011; 39(1):78-85. PubMed ID: 21672310
[TBL] [Abstract][Full Text] [Related]
25. Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers.
Sasaki H; Lo KM; Chen LB; Auclair D; Nakashima Y; Moriyama S; Fukai I; Tam C; Loda M; Fujii Y
Jpn J Cancer Res; 2001 Aug; 92(8):869-73. PubMed ID: 11509119
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
[TBL] [Abstract][Full Text] [Related]
27. CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.
Paulsen EE; Kilvaer T; Khanehkenari MR; Maurseth RJ; Al-Saad S; Hald SM; Al-Shibli K; Andersen S; Richardsen E; Busund LT; Bremnes R; Donnem T
Neoplasia; 2015 Nov; 17(11):839-48. PubMed ID: 26678911
[TBL] [Abstract][Full Text] [Related]
28. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues
and Associated with Poor Prognosis in Lung Adenocarcinoma Patients].
Wang M; Feng L; Li P; Han N; Gao Y; Xiao T
Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):64-9. PubMed ID: 26903158
[TBL] [Abstract][Full Text] [Related]
29. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
30. Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer.
Lin C; Majoor CJ; Roelofs JJ; de Kruif MD; Horlings HM; Borensztajn K; Spek CA
BMC Cancer; 2017 Feb; 17(1):113. PubMed ID: 28173772
[TBL] [Abstract][Full Text] [Related]
31. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
32. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
33. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
[TBL] [Abstract][Full Text] [Related]
34. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
35. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
[TBL] [Abstract][Full Text] [Related]
36. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
37. Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma.
Sung PL; Jan YH; Lin SC; Huang CC; Lin H; Wen KC; Chao KC; Lai CR; Wang PH; Chuang CM; Wu HH; Twu NF; Yen MS; Hsiao M; Huang CY
Oncotarget; 2016 Jan; 7(4):4036-47. PubMed ID: 26716408
[TBL] [Abstract][Full Text] [Related]
38. Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro.
Hong L; Sun H; Lv X; Yang D; Zhang J; Shi Y
Mol Biol Rep; 2010 Jun; 37(5):2285-93. PubMed ID: 19688273
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma.
Shimizu K; Kirita K; Aokage K; Kojima M; Hishida T; Kuwata T; Fujii S; Ochiai A; Funai K; Yoshida J; Tsuboi M; Ishii G
J Cancer Res Clin Oncol; 2017 Feb; 143(2):321-328. PubMed ID: 27771795
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
